Manulife (Manufacturers Life Insurance)
VXRT

Manulife (Manufacturers Life Insurance)’s Vaxart VXRT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-49,531
Closed -$37.5K – 3060
2023
Q1 		$37.5K Hold
49,531
– – ﹤0.01% 2892
2022
Q4 		$47.6K Buy
49,531
+251
+0.5% +$355 ﹤0.01% 2920
2022
Q3 		$107K Sell
49,280
-1,315
-3% -$4.54K ﹤0.01% 2794
2022
Q2 		$177K Buy
50,595
+401
+0.8% +$1.5K ﹤0.01% 2718
2022
Q1 		$253K Sell
50,194
-12,715
-20% -$64.4K ﹤0.01% 2616
2021
Q4 		$394 Buy
62,909
+700
+1% +$4.78K ﹤0.01% 2423
2021
Q3 		$495K Sell
62,209
-5,129
-8% -$42.2K ﹤0.01% 2294
2021
Q2 		$504K Buy
67,338
+36,423
+118% +$254K ﹤0.01% 2422
2021
Q1 		$187K Sell
30,915
-1,489
-5% -$11.5K ﹤0.01% 2920
2020
Q4 		$185K Buy
32,404
+2,217
+7% +$14.1K ﹤0.01% 2805
2020
Q3 		$201K Buy
30,187
+3,005
+11% +$26.8K ﹤0.01% 2567
2020
Q2 		$204K Buy
+27,182
New +$78.1K ﹤0.01% 2490
2016
Q3 		– Sell
-380
Closed -$6K – 4362
2016
Q2 		$6K Hold
380
– – ﹤0.01% 3770
2016
Q1 		$6K Hold
380
– – ﹤0.01% 3754
2015
Q4 		$8 Hold
380
– – ﹤0.01% 3582
2015
Q3 		$8 Hold
380
– – ﹤0.01% 3594
2015
Q2 		$9 Buy
+380
New +$9.33K ﹤0.01% 3581
2015
Q1 		– Sell
-3
Closed – – 4044
2014
Q4 		$0 Sell
3
-211
-99% -$5.41K ﹤0.01% 4048
2014
Q3 		$6 Sell
214
-41
-16% -$1.18K ﹤0.01% 3598
2014
Q2 		$8K Sell
255
-3
-1% -$125 ﹤0.01% 3433
2014
Q1 		$17 Buy
258
+44
+21% +$2.72K ﹤0.01% 3315
2013
Q4 		$10 Buy
214
+142
+197% +$6.25K ﹤0.01% 3368
2013
Q3 		$3 Buy
72
+5
+7% +$217 ﹤0.01% 3474
2013
Q2 		$3K Buy
+67
New +$2.78K ﹤0.01% 3365

Other funds holding VXRT

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VXRT Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 49,531 shares — an estimated $37.5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in VXRT in Q2 2013 and held it in 24 quarters. The position peaked at $504K in Q2 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 49,531 Vaxart shares in Q2 2023, an estimated $37.5K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Vaxart in Q2 2013 and held it in 24 quarters.
  • Manulife (Manufacturers Life Insurance)'s Vaxart position peaked at $504K in Q2 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.